WHO Says Risk 'Low' From COVID Strain Deemed 'Variant of Interest'

Video Credit: Wibbitz Top Stories
Published on December 19, 2023 - Duration: 01:31s

WHO Says Risk 'Low' From COVID Strain Deemed 'Variant of Interest'

WHO Says Risk 'Low' , From COVID Strain Deemed , 'Variant of Interest'.

'The Independent' reports that the JN.1 variant of COVID-19 has been classified as a "variant of interest" by officials who added that it poses a minor threat to public health.

On December 19, the World Health Organization (WHO) said that the risk from the JN.1 variant remains "low," based on current evidence.

Previously, this variant was classified as a variant of interest due to its lineage with the Omicron variant, otherwise known as BA.2.86.

According to the WHO, current vaccines continue to offer protection from severe disease and death from JN.1 and other COVID variants currently in circulation.

According to the WHO, current vaccines continue to offer protection from severe disease and death from JN.1 and other COVID variants currently in circulation.

Earlier this month, the Centers for Disease Control and Prevention said that the JN.1 subvariant accounts for an estimated 15% to 29% of current cases in the U.S. In August, JN.1 was first detected in Luxembourg, before later being detected in other countries that included the U.S., U.K. and France.

Last week, seven cases of the JN.1 subvariant were detected in China.

According to the most recent data, COVID cases are also on the rise in England, with 5,975 new cases reported in the week ending December 9.

.

'The Independent' reports that JN.1 has been deemed "of interest" by the UK Health Security Agency (UKHSA) due to its mutation and , "increasing prevalence within the UK and international data.".

According to the head of primary care and public health at Imperial College London, Prof Azeem Majeed, JN.1 , “appears to be the fastest growing variant in the UK at the moment.”


You are here


💡 newsR Knowledge: Other News Mentions



COVID-19

Contagious disease caused by SARS-CoV-2
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
Credit: DNA - Published 21 hours ago

Two companies are being sued by the British government for over £145m after they allegedly supplied defective COVID-19 tests.
Credit: Sky News - Published 1 day ago

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known..
Credit: Sky News - Published 2 days ago

Baba Ramdev crossed a red line when he claimed he could cure Covid-19 and at the same time maligned modern medicine by calling it a "stupid and bankrupt..
Credit: IndiaTimes - Published 2 days ago




Related news from verified sources

The World Health Organisation (WHO) has urged countries in South-East Asia to strengthen surveillance for respiratory diseases, including Covid-19 and its new...
on December 24, 2023 • IndiaTimes

The World Health Organisation (WHO) has classified the new strain as a separate "variant of interest" given its rapidly increasing spread but said that it poses...
on December 24, 2023 • DNA

JN.1 has been classified by the World Health Organization (WHO) as a variant of interest, distinct from its parent lineage BA.2.86. The WHO underscores a low...
on December 27, 2023 • DNA

Related videos from verified sources

JN.1 Covid Variant: New strain could trigger a global heart failure pandemic, fear experts| Oneindia 02:19
Video credit: Oneindia - Published on December 29, 2023 

WHO classifies JN.1 as Covid19 ‘Variant of Interest’ | What does it mean? | Oneindia News 03:01
Video credit: Oneindia - Published on December 20, 2023 

You might like